Dublin, Aug. 10, 2021 (GLOBE NEWSWIRE) -- The "Molecular Quality Controls Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Analyte Type, Application, and End User and Geography" report has been added to ResearchAndMarkets.com's offering.
According to this report the market is expected to reach US$ 372.64 million in 2028 from US$ 184.62 million in 2021; it is estimated to grow at a CAGR of 10.6% during 2021-2028. The report highlights major market drivers and prominent companies along with their key developments in the market.
According to the WHo suggestions, 30-50% of deaths caused due to cancer can be prevented by adequate treatment in early stages. In this scenario, personalized medicine offers the most promising approach to tackle diseases that have not been well-known for responding effectively to the existing treatments or cures. As per the personalized medicine report published in the PMC (Personalized Medicine Coalition), personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 27% of the same in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Also, as per the PMC, biopharmaceutical companies have almost doubled their R&D investments in personalized drugs in the past five years, and they are expected to increase by 33% in the next five years. The same report also mentioned that biopharmaceutical researchers also predict a 69% increase in the number of personalized medicines in development in the coming five years.
Further, in September 2018, Congenica-a diagnostic decision support platform provider-agreed with Digital China Health Technologies Cooperation Limited (DCHealth) to introduce a genomic medicine in the Chinese market. The increasing adoption of personalized medicines, based on patient's genetic information, for disease treatments is expected to favor the growth of the molecular quality controls market in the coming years.
Geographically, the molecular quality controls market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SCAM). North America held the largest market share in 2020. The growth in North America is characterized by increasing incidence of cancer, established key market players, and extensive R&D conducted by various academic and research institutes. Additionally, increasing incidence of COVID-19 support the growth of the market during forecast period. In April 2020, Thermo Fisher Scientific launched AcroMetrix Coronavirus 2019 (COVID-19) RNA Control to monitor and validate COVID-19 molecular diagnostic tests. Thus, rising numbers of product launches support the growth of the market.
Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; F. Hoffmann la-Roche Ltd; Abbott; Quidel Corporation; Qnostics; Maine Molecular Controls Inc; Zeptometrix Corporation; Microbiologics and Seracare Life Sciences are among the leading companies operating in the molecular quality controls market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the molecular quality controls market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global molecular quality controls market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Key Topics Covered:
1. Introduction
2. Molecular Quality Controls Market - Key Takeaways
3. Research Methodology
4. Global Molecular Quality Controls Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.1 Expert Opinions
5. Molecular Quality Controls Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Funds for Genomics
5.1.2 Declining Cost of Sequencing Procedures
5.1.3 Increasing Prevalence of Genetic Diseases
5.2 Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Rise in Adoption of Molecular Diagnostics
5.4 Future Trends
5.4.1 Burgeoning Demand for Personalized Medicines
5.5 Impact analysis
6. Molecular Quality Controls Market - Global Analysis
6.1 Global Molecular Quality Controls Market Revenue Forecast and Analysis
6.2 Global Molecular Quality Controls Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Molecular Quality Controls Market Analysis - By Product
7.1 Overview
7.2 Molecular Quality Controls Market Revenue Share, by Product 2020 and 2028)
7.3 Independent Controls
7.3.1 Overview
7.3.2 Independent Controls: Molecular Quality Controls Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Instrument Specific Controls
7.4.1 Overview
7.4.2 Instrument Specific Controls: Molecular Quality Controls Market- Revenue and Forecast to 2028 (US$ Million)
7.4.3 PCR
7.4.3.1 Overview
7.4.3.2 PCR: Molecular Quality Controls Market- Revenue and Forecast to 2028 (US$ Million)
7.4.4 DNA Sequencing and NGS
7.4.4.1 Overview
7.4.4.2 DNA Sequencing and NGS: Molecular Quality Controls Market- Revenue and Forecast to 2028 (US$ Million)
8. Molecular Quality Controls Market - By Analyte Type
8.1 Overview
8.2 Molecular Quality Controls Market, by Analyte Type, 2020 and 2028 (%)
8.3 Single Analyte Controls
8.3.1 Overview
8.3.2 Single Analyte Controls: Molecular Quality Controls Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Multi-Analyte Controls
8.4.1 Overview
8.4.2 Multi-Analyte Controls: Molecular Quality Controls Market - Revenue and Forecast to 2028 (US$ Million)
9. Molecular Quality Control Market Analysis - By Application
9.1 Overview
9.2 Molecular Quality Control Market Revenue Share, by Application (2020 and 2028)
9.3 Infectious Diseases
9.3.1 Overview
9.3.2 Infectious Diseases: Molecular Quality Control Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Molecular Quality Control Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Genetic Testing
9.5.1 Overview
9.5.2 Genetic Testing: Molecular Quality Control Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Other Applications
9.6.1 Overview
9.6.2 Other Applications: Molecular Quality Control Market - Revenue and Forecast to 2028 (US$ Million)
10. Molecular Quality Control Market Analysis - By End User
10.1 Overview
10.2 Molecular Quality Control Market Share, by End User, 2020 and 2028, (%)
10.3 Clinical laboratory
10.3.1 Overview
10.3.2 Clinical Laboratory: Molecular Quality Control Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Hospitals
10.4.1 Overview
10.4.2 Hospitals: Molecular Quality Control Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Academic and Research Institutes
10.5.1 Overview
10.5.2 Academic and Research Institutes: Molecular Quality Control Market - Revenue and Forecast to 2028 (US$ Million)
10.6 IVD Manufacturers and Contract Research Organizations
10.6.1 Overview
10.6.2 IVD Manufacturers & Contract Research Organizations: Molecular Quality Control Market - Revenue and Forecast to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Molecular Quality Control Market - Revenue and Forecast to 2028 (US$ Million)
11. Molecular Quality Controls Market - Geographical Analysis
12. Impact of COVID-19 Pandemic on Global Molecular Quality Controls Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 BIO-RAD LABORATORIES INC.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Abbott
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Quidel Corporation
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Qnostics
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Maine Molecular Quality Controls Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Zeptometrix Corporation
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Microbiologics
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Seracare Life Sciences
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/xr0qqu
